Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3699956 A
Publication typeGrant
Publication date24 Oct 1972
Filing date1 Oct 1970
Priority date1 Oct 1970
Also published asDE2149041A1
Publication numberUS 3699956 A, US 3699956A, US-A-3699956, US3699956 A, US3699956A
InventorsSotiris Kitrilakis, Thomas C Robinson
Original AssigneeTecna Corp
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Percutaneous lead device
US 3699956 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent Kitrilakis et al.

[451 Oct. 24, 1972 [54] PERCUTANEOUS LEAD DEVICE [72] Inventors: Sotiris Kitrilakis, Berkeley; Thomas C. Robinson, El Cerrito, both of Calif.

[73] Assignee: Tecna Corporation, Berkeley, Calif.

[22] Filed: Oct. 1, 1970 [21] Appl. No.: 77,290

[52] US. Cl. ..128/348, 128/260, 3/1 [51] Int. Cl. ..-.....A6lm 25/00 [58] Field of Search ...l28/348, 349 R,'350 R, 214.4,

[56] References Cited UNITED STATES PATENTS- 3,447,161 6/1969 Weikel .Q ..3/1 3,279,996 10/ 1966 Long et al ..424/l9 3,461,869

8/1969 Hargest ..128/348 X OTHER PUBLICATIONS Ersek et al Trans. Amer. Soc. Artif. Int. Orgs. 1969,

Vol. XV, 1969 (June) pp. 267- 271. McDonald et al. Trans. Amer. Soc. Artif. Int. Orgs. V01. XIV 1968 pp. 176- 180.

Primary Examiner-Dalton L. Truluck Attorney -Flehr, Hohbach, Test, Albritton & Herbert 7] ABSTRACT A percutaneous lead device including an element for preventing bacterial infection caused by implanting the lead through the skin. This element extends below and along the skin surface and includes an antibacterial fluid reservoir coated with a diffusion-controlling layer which maintains the desired fluid release rate. A surface configuration on the reservoir and lead which is highly adherent to and completely permeated by ingrowing tissue provides a particularly effective bacterial seal.

9 Claims, 2 Drawing Figures PERCUTANEOUS LEAD DEVICE BACKGROUND OF THE INVENTION This invention relates generally to method and means for preventing bacterial infection caused by implanting a percutaneous lead device in the skin and for achieving good fixation to minimize bacterial penetration and to avoid accidental removal of the lead.

Percutaneous lead devices such as tubes, shunts, cannulae, insulated wire, and various rods or tubular devices have been implanted through the skin for a wide variety of reasons. For example, such devices are used temporarily or over long periods of time to provide access to the circulated blood for blood pressure monitoring, blood sampling, the infusion of various substances, and the like. These lead devices are also used to connect external equipment to implanted devices, such as blood-flow probes, blood pumps, and pace makers. Two particularly widespread uses are as blood vessel connections in hemodialysis and as abdominal cavity access tubes for peritoneal dialysis. Both dialysis techniques are important tools in the treatment of kidney failure.

Although there is a substantial need for chronic, or long-term, use of percutaneous lead devices of the aforementioned type, the presently-available lead devices tend to cause infection by bacteria being transmitted across the skin and along the boundary between such devices and the surrounding skin tissue. Use of topical antibiotics at the skin puncture or the use of systemic antibiotics have been only marginally successful in the control of such infections since surface or systemic bacterial control does not prevent the eventual infection of the internal tissue. The only effective treatment of infections along present leads has been the removal of the lead and infected tissue, necessitating the implantation of a lead in a new site. Such untreated local infections will eventually result in systemic infections.

SUMMARY OFTHE INVENTION AND OBJECTS In accordance with the present invention, method and means are provided at a peripheral portion of a percutaneous lead device for releasing antibacterial fluid into the surrounding tissue at a controlled rate upon implanting the lead device into the skin. The release means includes a fluid reservoir, such as an absorptive material to which the antibacterial fluid is applied carried by a peripheral lead portion. In on embodiment, the coating material contains a plurality of microcavities which are compatible with blood and living tissue and form a tenacious base for anchoring tissue ingrowth which minimizes bacterial penetration along the lead surface.

It is a general object of the present invention to provide a method and means for preventing infection in a percutaneous lead device when implanted in the skin caused by bacteria being transmitted along the surface.

It is another object of the invention to provide a method and means for the controlled release of antibacterial fluid from the surface of a percutaneous lead device.

It is another object of the invention to provide a method and means for obtaining tissue fixation which avoids movement of the lead relative to adjacent tissue or accidental detachment or removal.

The foregoing and other objects will become apparent from the following description when taken in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWING FIG. 1 is an enlarged view of a portion of skin and subcutaneous tissue together with a percutaneous lead device according to the invention; and

FIG. 2 is an enlarged view of the portion of FIG. 1 showing the release device of the invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring to the drawing, percutaneous lead line 10 in the form of a hollow tube is illustrated in an implanted positionafter penetration through skin 11 and subcutaneous tissue 12. Line 10 may also be a solid rod such as an insulated wire for monitoring purposes. Various uses for either type of percutaneous lead line are described hereinbefore. In one embodiment, line 10 includes an outer wall containing a plurality of microcavities 13, such as formed in accordance with the method set forth in the copending application Ser. No. 77,289, filed Oct. 1, 1970. These microcavities allow the skin and subcutaneous tissue to grow around the outside walls and become permanently fixed or anchored to the wall by tissue ingrowth.

As further disclosed in the aforementioned application, the lead wall material may be rigid or flexible, depending upon the particular use of the lead line. A flexible lead line has the desirable property of reducing surface shear forces as caused by body movement or external forces applied to the line.

An additional technique to increase surface area and reduce shear stresses as illustrated in FIG. 1 is the disposition of a subcutaneous portion of the lead line generally parallel to the skin surface. This additional length provides increased fixation as well as other advantages discussed below.

Tissue growth in the microcavities forms a generally sealing interface which effectively blocks the ingress of infection causingbacteria across the skin for prolonged periods of time. However, this tissue seal is not completed until growth of the surrounding tissue into all interstices of the microcavity surface structure takes place. Even though this seal is formed in a relatively short period of time (e. g., several days), it is necessary to prevent bacterial penetration into the tissue along the lead surface during seal formation. This protection is provided by the means described herein.

According to the invention, microcavity-containing lead lines achieve long-term use by antiseptically preventing early bacterial infections below the skin. For this purpose, (e.g., antibacterial fluid reservoir 14 is mounted onto peripheral lead portion 10a. To provide a slow release of the fluid so that it is available for a prolonged period of time, a diffusion-controlling layer in the form of coating 16 is mounted or applied to lead portion over essentially the entire area of reservoir 14 so that the reservoir is sealed. at its proximal and distal ends. In one embodiment, reservoir 14 is an antibacterial fluid containing a wick-like absorbant material such as porous cloth (e.g., knitted or woven Dacron) or a fibrous mat e.g., Teflon felt). The antibacterial agent is applied to the material and released at a controlled rate through the diffusion-controlling layer 16 into the skin.

In one embodiment of a diffusion-controlling layer 16 shown in the drawings, a plurality of elongated passages 17 are provided throughout the layer to promote the desired diffusion rate. Passages 17 may be formed in a similar manner to microcavities 13 or by physically puncturing or perforating the layer. Passages 17 may be supplemented by microcavities 18 of the same type as microcavities 13 throughout the coating in such a manner that they are linked with passages 17 to form paths through the coating of sufficient size and density to accomplish the desired diffusion properties. Microcavities 18 also serve to permit tissue ingrowth and adhesion to prevent bacterial penetration along the surface of the layer. In an example of one such coating, an average of about 100 penetrations per cm of 0.1 mm length and 0.05 mm width are positioned throughout the layer. A typical thickness for such a layer is 0.001 to 0.020 inch.

- In another embodiment of a diffusion-controlling element (not shown), microcavity surface material may inherently possess the desired diffusion rate without the need for passages 17, as exemplified by Dacron cloth or a silicone rubber membrane layer.

The antibacterial fluid in reservoir 14 is of a type which is capable of allowing tissue growth on the outer surface of the percutaneous lead device while preventing bacterial infection. Suitable fluids include the following: maphenide acetate, silver nitrate, and silver sulfadiazine, and the like.

Antibiotic treatment is primarily beneficial from the time of implantation until tissue ingrowth occurs creating an effective bacterial seal at the tissue-microcavity surface. Thus, the antibiotic is supplied in amounts to be consumed at approximately that time.

The antibiotic treatment is maintained until complete tissue ingrowth and fixation occur, and may be discontinued at this time because an effective bacterial seal is created at the tissue-microcavity surface. If antibiotic treatment is discontinued, then means for preventing bacterial invasion of reservoir 14 are provided. These means include an impervious coating external to the skin (coating 18) which is either applied prior to implantation or at the time antibacterial treatment is stopped. If the reservoir is wholly beneath the surface of the skin, then no surface coating need be applied. In either case, the reservoir can be filled with an inert substance (curable silicon rubber, silicone grease) to prevent bacterial growth within the reservoir.

In general, it is noted that reservoir 14 may extend to any desired degree above the surface of the skin or therebelow. The reservoir may extend above the skin or may terminate just below the skin in the subcutaneous tissue as shown in FIG. 1.

After depletion of antibiotic, a pathway may be formed for bacteria through the porous coating 16 and empty reservoir 14 into the skin. To prevent this, it is preferred to terminate the reservoir and coating just below the skin in the subcutaneous tissue so that permeable layer 16 is not exposed. If it is desired to extend the reservoir above the skin, then the externally projecting portion of layer 16 should be rendered impermeable as by application of an impermeable coating prior to implantation or after termination of treatment.

Depletion of antibiotic fluid may also provide a site for bacteria growth in body fluids which difiuse through layer 16. This may be avoided by filling the depleted reservoir with an inert substance (e.g., curable silicone rubber or silicone grease) after antibiotic fluid depletion.

To form the antiseptic means for preventing infection according to the invention, the bacterial fluid is first supplied to reservoir 14 either before mounting layer 16 or thereafter as through a hypodermic needle penetrating the coating.

We claim:

1. A percutaneous device comprising an elongated lead adapted to penetrate the skin, said lead including a portion having an external surface compatible with skin, subcutaneous tissue and other tissue, said surface including pockets extending into said surface for receiving ingrowth of living cells to permanently anchor the lead, antiseptic means including an antibacterial fluid reservoir for providing a controlled release of said fluid adjacent said portion of the lead, said reservoir including a walled chamber attached to said lead, said chamber walls provided with diffusion controlling passage means so that upon penetration of the skin by the device the fluid is released directly from said reservoir into the area around said reservoir portion over a prolonged period of time to prevent bacterial penetration into the tissue along the lead during ingrowth of said cells.

2. A lead device as in claim 1 in which said reservoir comprises an antibacterial fluid-containing absorptive material carried within said chamber of the lead.

3. A percutaneous lead as in claim 2 in which said release means includes a permeable barrier covering said absorptive material.

4. A percutaneous lead device as in claim 3 in which said barrier is a layer extending over essentially the entire surface of the absorptive material.

5. A percutaneous lead device as in claim 4 in which said layer is covered by a material which is compatible with living tissue having a plurality of microcavities of predetermined size and shape.

6. A percutaneous lead device as in claim 4 in which said layer has a thickness of from 0.001 to 0.020 inch.

7. A percutaneous lead as in claim 4 in which said layer is capable of anchoring tissue ingrowth on its outer surface.

8. A percutaneous lead device as in claim 5 including elongated passages through said layer of a size sufficient for permeability.

9. A percutaneous device comprising an elongated hollow lead adapted to penetrate the skin, said lead including a portion having a flexible external surface compatible with skin, subcutaneous tissue and other tissue, said surface portion including a plurality of adjacent substantially discrete pockets having openings which face toward the tissue, the walls of said pocket being of such shape and size as to provide means to accommodate a number of living cells sufficient to provide anchoring but not so large as to prevent essentially normal transfer of nutrients to said living cells in said pockets from said adjacent area of tissue, antiseptic means including an antibacterial fluid reservoir for providing a controlled release of said fluid adjacent said portion of the lead, said reservoir including a walled chamber attached to said lead, said chamber walls provided with diffusion controlling passage means so that upon penetration of the skin by the device the fluid is released directly from said reservoir into the area around said reservoir portion over a prolonged 5 period of time to prevent bacterial penetration into the tissue along the lead during ingrowth of said cells.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3752162 *10 Apr 197214 Aug 1973Dow CorningArtificial cutaneous stoma
US3797485 *26 Mar 197119 Mar 1974Alza CorpNovel drug delivery device for administering drug into blood circulation in blood vessel
US3804088 *31 Jul 197216 Apr 1974Lilly Co EliRemovable implantate for administering physiological active agents to animals
US3843974 *5 Jan 197229 Oct 1974Us Health Education & WelfareIntimal lining and pump with vertically drafted webs
US3877461 *2 Jul 197315 Apr 1975Investors In Ventures IncDevice for controlling body fluids
US4054139 *20 Nov 197518 Oct 1977Crossley Kent BOligodynamic catheter
US4321914 *22 Apr 198030 Mar 1982W. L. Gore & Associates, Inc.Percutaneous conduit having PTFE skirt
US4343788 *29 Jun 197910 Aug 1982The Procter & Gamble CompanyAntimicrobial polymer compositions
US4392848 *25 Jun 197912 Jul 1983The Procter & Gamble CompanyCatheterization
US4479795 *27 Jul 198230 Oct 1984The Procter & Gamble CompanyFor catheters
US4483688 *28 Feb 198320 Nov 1984Hiroshi AkiyamaCatheter
US4515593 *31 Dec 19817 May 1985C. R. Bard, Inc.Medical tubing having exterior hydrophilic coating for microbiocide absorption therein and method for using same
US4564361 *21 Aug 198414 Jan 1986Hiroshi AkiyamaCatheter
US4588404 *18 Mar 198213 May 1986Didier LapeyreTotal cardiac prosthesis
US4623329 *15 Dec 198318 Nov 1986The Procter & Gamble CompanyDrainage and infusion catheters having a capillary sleeve forming a reservoir for a fluid antimicrobial agent
US4624669 *26 Sep 198425 Nov 1986Surgidev CorporationCorneal inlay with holes
US4676782 *13 May 198630 Jun 1987Vitaphore CorporationPositionable tissue interfacing device for the management of percutaneous conduits
US4810241 *19 Mar 19877 Mar 1989Rogers Phillip PProtecting a tube connection from contamination
US4863426 *18 Aug 19875 Sep 1989Ferragamo Michael CPercutaneous venous catheter
US4886501 *6 Feb 198912 Dec 1989Shiley Infusaid Inc.Implantable device
US4886502 *9 Dec 198612 Dec 1989Thermedics, Inc.Peritoneal access catheter
US5007897 *30 May 198916 Apr 1991Kalb Irvin MDrug delivery catheter
US5019096 *14 Oct 198828 May 1991Trustees Of Columbia University In The City Of New YorkInfection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5053013 *18 Jun 19901 Oct 1991The Regents Of The University Of MichiganImplantable infusion device
US5057084 *1 Mar 199015 Oct 1991The Regents Of The University Of MichiganImplantable infusion device
US5059186 *23 Mar 198922 Oct 1991Vitaphore CorporationPercutaneous access device
US5098379 *1 Mar 199024 Mar 1992Rochester Medical CorporationCatheter having lubricated outer sleeve and methods for making and using same
US5100383 *24 Jul 199031 Mar 1992Meir LichtensteinCatheters permitting controlled diffusion
US5100392 *8 Dec 198931 Mar 1992Biosynthesis, Inc.Implantable device for administration of drugs or other liquid solutions
US5180365 *15 Feb 199119 Jan 1993Ensminger William DImplantable infusion device
US5226879 *10 Jan 199213 Jul 1993William D. EnsmingerImplantable access device
US5236422 *24 Jun 199117 Aug 1993Eplett Jr James DAntiseptic urinary catheter cuff
US5261896 *13 Dec 199116 Nov 1993Rochester Medical CorporationSustained release bactericidal cannula
US5263930 *4 Sep 199223 Nov 1993William D. EnsmingerImplantable access devices
US5269770 *13 Mar 199214 Dec 1993Rochester Medical CorporationMicrocidal agent releasing catheter with balloon
US5281199 *4 Sep 199225 Jan 1994Michigan Transtech CorporationImplantable access devices
US5308338 *22 Apr 19933 May 1994Helfrich G BairdCatheter or the like with medication injector to prevent infection
US5350360 *8 Oct 199327 Sep 1994Michigan Transtech CorporationImplantable access devices
US5352204 *29 Sep 19934 Oct 1994Ensminger William DImplantable access devices
US5356381 *24 Nov 199318 Oct 1994Ensminger William DImplantable access devices
US5360402 *29 Jan 19921 Nov 1994Rochester Medical CorporationHand-actuated retention catheter
US5370899 *13 Mar 19926 Dec 1994Conway; Anthony J.Outer sleeves that are lubricated so they can slide independently
US5395651 *10 Jun 19927 Mar 1995Ad Tech Holdings LimitedDeposition of silver layer on nonconducting substrate
US5417656 *13 Jun 199423 May 1995Michigan Transtech CorporationImplantable access devices
US5451424 *24 Nov 199219 Sep 1995Becton Dickinson And CompanyAnti-infective and antithrombogenic medical articles and method for their preparation
US5468562 *10 Feb 199421 Nov 1995Spire CorporationMetallized polymeric implant with ion embedded coating
US5474797 *10 Feb 199412 Dec 1995Spire CorporationVapor ionizing process
US5482740 *8 Nov 19939 Jan 1996Rochester Medical CorporationCured silicone rubber containing particles of nitrofuran compound; urinary catheters
US5492763 *10 Feb 199420 Feb 1996Spire CorporationA subsurface bacteriostatic/bactericidal stratum introduced by ion implantation
US5501669 *30 Mar 199526 Mar 1996Rochester Medical CorporationUrinary catheter with reservoir shroud
US5503630 *6 Jun 19952 Apr 1996Michigan Transtech CorporationInplantable access devices
US5505695 *12 Apr 19959 Apr 1996Eplett, Jr.; James D.Method of preventing bacterial migration during a urethral catheterization procedure
US5520643 *6 Jun 199528 May 1996Michigan Transtech CorporationImplantable access devices
US5520664 *11 Jan 199428 May 1996Spire CorporationApplying nonleaching metal
US5527277 *6 Jun 199518 Jun 1996Michigan Transtech CorporationImplantable access devices
US5527278 *6 Jun 199518 Jun 1996Michigan Transtech CorporationImplantable access devices
US5531684 *6 Jun 19952 Jul 1996Michigan Transtech CorporationFor permitting access to a predetermined tissue
US5534288 *16 Feb 19959 Jul 1996United States Surgical CorporationInfection-resistant surgical devices and methods of making them
US5542923 *6 Jun 19956 Aug 1996Michigan Transtech CorporationImplantable access devices
US5545223 *30 Mar 199513 Aug 1996Baxter International, Inc.Ported tissue implant systems and methods of using same
US5554117 *15 May 199510 Sep 1996Michigan Transtech CorporationImplantable access devices
US5556381 *6 Jun 199517 Sep 1996The Michigan Transtech CorporationImplantable access devices
US5569462 *31 Mar 199529 Oct 1996Baxter International Inc.Placing a population of therapeutic substance producing cells into cell receiving chamber of immunoisolation apparatus, implanting apparatus into patient, administering an immunomodulatory agent
US5588962 *29 Mar 199431 Dec 1996Boston Scientific CorporationDrug treatment of diseased sites deep within the body
US5593718 *2 Aug 199414 Jan 1997Rochester Medical CorporationMethod of making catheter
US5599298 *30 Dec 19934 Feb 1997Boston Scientific CorporationBodily sample collection balloon catheter method
US5599321 *7 Jun 19954 Feb 1997Rochester Medical CorporationCoating outer surface of tube with mixture of uncured silicone rubber, silicone fluid and and particles of antibacterial agent, then curing, for urinary catheters
US5607393 *6 Jun 19954 Mar 1997Michigan Transtech CorporationImplantable access devices
US5670111 *2 Aug 199423 Sep 1997Rochester Medical CorporationCoating with bond-preventing agent; forming cavities that may be fluid or gel filled
US5674192 *23 Jul 19937 Oct 1997Boston Scientific CorporationDrug delivery
US5707366 *7 Jun 199513 Jan 1998Becton Dickinson And CompanyAnti-infective and antithrombogenic medical articles and method for their preparation
US5713859 *18 Apr 19963 Feb 1998Vasca, Inc.For performing extracorporeal blood treatment
US5733336 *30 Mar 199531 Mar 1998Baxter International, Inc.Ported tissue implant systems and methods of using same
US5747178 *6 Mar 19955 May 1998Adtech HoldingThin silver films on nonconductors
US5755780 *7 Nov 199626 May 1998Vasca, Inc.Implantable vascular device
US5756145 *8 Nov 199526 May 1998Baylor College Of MedicineDurable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor
US5792123 *24 Jul 199711 Aug 1998Michigan Transtech CorporationImplantable access devices
US5807356 *4 Oct 199515 Sep 1998Vasca, Inc.For implantation in a vascular structure
US5843089 *20 Sep 19961 Dec 1998Boston Scientific CorporationStent lining
US5868719 *15 Jan 19979 Feb 1999Boston Scientific CorporationDrug delivery balloon catheter device
US5919145 *24 Jan 19976 Jul 1999Boston Scientific CorporationBodily sample collection balloon catheter
US5954706 *7 Jun 199521 Sep 1999Boston Scientific CorporationDrug delivery
US5964804 *7 Jun 199512 Oct 1999Baxter International Inc.Close vascularization implant material
US5965204 *4 May 199812 Oct 1999Ad Tech Holdings LimitedDeposition of silver layer on nonconducting substrate
US5971954 *29 Jan 199726 Oct 1999Rochester Medical CorporationMethod of making catheter
US6053901 *2 Oct 199625 Apr 2000Vasca, Inc.Subcutaneously implanted cannula and method for arterial access
US6056717 *2 Feb 19982 May 2000Vasca, Inc.Implantable vascular device
US6110481 *4 Mar 199429 Aug 2000Trustees Of The Stevens Institute Of TechnologyA controlled release dispenser employing microporous membranes with or without a nonporous coating and aqueous-organic partitioning of the bioreactive substances such as pesticides, hormones, nutrients and fragrances to humans or animals
US6156305 *5 Jun 19955 Dec 2000Baxter International Inc.Implanted tumor cells for the prevention and treatment of cancer
US6162487 *27 Mar 199719 Dec 2000Baylor College Of MedicineImplantable
US61937464 Sep 199627 Feb 2001Ernst Peter StreckerEndoprosthesis that can be percutaneously implanted in the patient's body
US622498313 Aug 19991 May 2001Ad Tech Holdings LimitedArticle that resists microbial growth,
US626127113 Jan 199817 Jul 2001Becton Dickinson And CompanyAnti-infective and antithrombogenic medical articles and method for their preparation
US630478629 Mar 199916 Oct 2001Cardiac Pacemakers, Inc.Implantable lead with dissolvable coating for improved fixation and extraction
US63648935 Aug 19982 Apr 2002Scimed Life Systems, Inc.Stent lining
US638343430 Jun 19997 May 2002Rochester Medical CorporationMethod of shaping structures with an overcoat layer including female urinary catheter
US639876427 Dec 19994 Jun 2002Vasca. Inc.Subcutaneously implanted cannula and method for arterial access
US64097167 Oct 199725 Jun 2002Scimed Life Systems, Inc.Drug delivery
US649486115 Jan 199717 Dec 2002Boston Scientific CorporationDrug delivery system
US6558686 *8 Nov 19956 May 2003Baylor College Of MedicineAntimicrobial coated implant; does not develop antibiotic resistance; combination of methylisothiazolone, thymol, chlorhexidine, chloroxylenol and/or cetylpyridinium chloride
US658436316 Jul 200124 Jun 2003Cardiac Pacemakers, Inc.Implantable lead with dissolvable coating for improved fixation and extraction
US662688826 Sep 199530 Sep 2003Rochester Medical CorporationMethod of shaping structures with an overcoat layer including female urinary catheter
US66452416 Feb 200111 Nov 2003Ernst Peter StreckerEndoprosthesis that can be percutaneously implanted in the patient's body
US689033931 Jan 200210 May 2005Scimed Life Systems, Inc.Stent lining
US721897124 Jun 200315 May 2007Cardiac Pacemakers, Inc.Implantable lead with dissolvable coating for improved fixation and extraction
US773168523 Sep 20058 Jun 2010Cook IncorporatedCoated medical device
US78202843 Dec 200226 Oct 2010C.R. Bard Inc.Such as an overcoated urinary catheters, condoms, and contact lenses
US803445410 Aug 200911 Oct 2011C.R. Bard, Inc.Antimicrobial compositions containing colloids of oligodynamic metals
US817279331 May 20058 May 2012Cook Medical Technologies LlcCoated medical device
US838314328 Nov 200726 Feb 2013The Trustees Of Columbia University In The City Of New YorkAntimicrobial medical devices containing chlorhexidine free base and salt
US867338726 Jan 200918 Mar 2014Cook Medical Technologies LlcCoated medical device
USH1465 *8 Sep 19934 Jul 1995Medtronic, Inc.Implantable lead infection barrier
DE3028512C2 *3 Jan 198021 Nov 1991Aktiebolaget Tesi, Stockholm, SeTitle not available
DE3937849A1 *14 Nov 198916 May 1991Frimberger Eckart Dr MedVorrichtung zur aussenversorung von perkutanen sonden
DE3943412A1 *30 Dec 198911 Jul 1991Braun Melsungen AgTranscutaner implantatkatheter
EP0022370A1 *7 Jul 198014 Jan 1981American Hospital Supply CorporationPeritoneal catheter
EP0703799A1 *20 Mar 19953 Apr 1996Minimed Inc.Indwelling catheter with stable enzyme coating
WO1984001102A1 *12 Sep 198329 Mar 1984Hydromer IncAnti-bacterial medical material and device
WO1990015636A1 *1 Jun 19903 Dec 1990Baxter IntPorous percutaneous access device
WO1991010466A1 *8 Jan 199111 Jul 1991Rochester Medical CorpMicrocidal agent releasing catheter
WO1991010467A1 *8 Jan 199125 Jul 1991Rochester Medical CorpCatheter having lubricated outer sleeve and method for making same
WO1995023598A1 *28 Feb 19958 Sep 1995Stevens Inst TechnologyControlled release microporous membranes
Classifications
U.S. Classification604/175, 424/449, 604/265
International ClassificationA61M1/00, A61L29/16
Cooperative ClassificationA61L29/16, A61L2300/404, A61M39/0247, A61M2039/0285
European ClassificationA61L29/16, A61M39/02T
Legal Events
DateCodeEventDescription
16 Feb 1990ASAssignment
Owner name: BELL, CHRISTY W.
Owner name: BRADLEY RESOURCES COMPANY
Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202
Owner name: GLENN, PAUL F.
Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202
Effective date: 19890628
Owner name: HILL, J. DONALD
18 Jul 1988AS06Security interest
Owner name: BELL, CHRISTY W., ( BELL )
Owner name: BRADLEY RESOURCES COMPANY
Owner name: GLENN, PAUL F., ( GLENN )
Effective date: 19880616
Owner name: THORATEC LABORATORIES CORPORATION, A CA CORP.
18 Jul 1988ASAssignment
Owner name: BELL, CHRISTY W., ( BELL )
Owner name: BRADLEY RESOURCES COMPANY ("BRADLEY"), A NEW YORK
Owner name: GLENN, PAUL F., ( GLENN )
Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CA CORP.;REEL/FRAME:004926/0506
Effective date: 19880616
15 Jul 1988ASAssignment
Owner name: BELL, CHRISTY W.
Owner name: BRADLEY RESOURCES COMPANY, A NEW YORK GENERAL PART
Owner name: GLENN, PAUL F.
Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CORP. OF CA.;REEL/FRAME:005049/0326
Effective date: 19880616
30 Jan 1987ASAssignment
Owner name: WELLS FARGO BANK N.A., 420 MONTGOMERY STREET, SAN
Free format text: SECURITY INTEREST;ASSIGNORS:THORATEC LABORATORIES INCORPORATED;THORATEC MEDICAL INCORPORATED;BIOTEXINDUSTRIES INCORPORATED MERCOR INCORPORATED;REEL/FRAME:004681/0966
Effective date: 19870122
30 Jan 1987AS06Security interest
Owner name: BIOTEX INDU
Owner name: THORATEC LABORATORIES INCORPORATED
Owner name: THORATEC MEDICAL INCORPORATED
Effective date: 19870122
Owner name: WELLS FARGO BANK N.A., 420 MONTGOMERY STREET, SAN
12 Dec 1984ASAssignment
Owner name: CROCKER NATIONAL BANK ONE MONTGOMERY ST., SAN FRAN
Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION A CA CORP;REEL/FRAME:004339/0427
Effective date: 19841207
Owner name: CROCKER NATIONAL BANK,CALIFORNIA
6 Dec 1982ASAssignment
Owner name: CROCKER NATIONAL BANK, ONE MONTGOMERY ST., SAN FRA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:THORATEC LABORATORIES CORPORATION A CA CORP.;REEL/FRAME:004066/0838
Effective date: 19821201